IP Library Assignment 010804/0904
Patent Assignment
Reel/Frame 010804/0904

Change of Address

Recorded: 2000-05-19 Pages: 5
Assignor
Assignee
APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
PIETERMAAI 15, CURACAO, ANTILLES, NETHERLANDS ANTILLES
Covered Properties (50)
Site-Directed Mutagenesis Modified Glycoprotein Hormones
Patent: 5,260,421 →
Application: 07/136,236 →
Urinary Follicle Stimulating Hormone
Patent: 5,128,453 →
Application: 07/337,766 →
Saf Polypeptide Gene Coding Therefor, and Saf Promoter
Patent: 5,122,595 →
Application: 07/354,265 →
Ovulation Kit Comprising Fsh Isoforms with Varying Half-Lives
Patent: 5,262,518 →
Application: 07/751,016 →
Protein Complex Enhancing Sperm Motility
Patent: 5,304,464 →
Application: 07/777,277 →
Method for the Modification of the Expression Characteristics of an Endogenous Gene of a Given Cell Line
Patent: 5,272,071 →
Application: 07/893,447 →
Method and Apparatus for Growing Biomass Particles
Patent: 5,654,197 →
Application: 08/102,098 →
Method for Impproving Sperm Motility
Patent: 5,453,354 →
Application: 08/108,000 →
Site-Directed Mutagenesis Modified Dna Encoding Glycoprotein Hormones and Methods of Use
Patent: 5,352,779 →
Application: 08/126,134 →
Gonadotropin Containing Pharmaceutical Compositions with Sucrose Stabilizer
Patent: 5,650,390 →
Application: 08/244,575 →
Site-Directed Mutagenesis Modified Glycoprotein Hormones and Methods of Use
Patent: 5,986,068 →
Application: 08/281,123 →
Human Fc Gamma Receptor Iii
Patent: 5,976,831 →
Application: 08/417,488 →
CD16-Ii Variants
Patent: 6,444,789 →
Application: 08/433,123 →
Site-Directed Mutagenesis Modified Glycoprotein Hormones and Methods of Use
Patent: 5,635,475 →
Application: 08/442,645 →
Site-Directed Mutagenesis Modified Glycoprotein Hormones and Methods of Use
Patent: 5,705,479 →
Application: 08/442,963 →
New Protein from Urine Named Component B
Patent: 5,908,827 →
Application: 08/448,561 →
Method of Expressing and Secreting Soluble Extracellular Domains of Human Gonadotropin Hormone Receptors
Patent: 6,033,903 →
Application: 08/460,576 →
Methods for Assaying Human Fsh Using Human Fsh Receptor
Patent: 6,372,711 →
Application: 08/474,986 →
Interleukin-1 Antagonist
Patent: 5,739,282 →
Application: 08/476,860 →
Human Fc-Gamma Receptor Iii
Patent: 5,767,077 →
Application: 08/481,939 →
Dna Encoding Human Follicle Stimulating Hormone Receptor,Vectors and Cells Containing Suchdna,and Methods of Use Thereof
Patent: 6,121,016 →
Application: 08/482,855 →
Human Follicle Stimulating Hormone Receptor
Patent: 5,744,448 →
Application: 08/487,886 →
CD16-Ii Variants
Patent: 5,998,166 →
Application: 08/667,939 →
Soluble Polypeptide Fractions of the Lag-3 Protein; Production Method, Therapeutic Composition, Anti-Idiotype Antibodies
Patent: 5,955,300 →
Application: 08/737,271 →
Hybrid Proteins
Patent: 6,193,972 →
Application: 08/804,166 →
Soluble Human Prolactin Receptors
Patent: 6,083,714 →
Application: 08/806,597 →
Dna Encoding Interleukin-1 Antagonist
Patent: 5,837,495 →
Application: 08/910,733 →
Antibodies to Interleukin-1 Antagonists.
Patent: 5,981,713 →
Application: 08/910,884 →
Hybrid Proteins
Patent: 6,194,177 →
Application: 08/910,991 →
Il-6 Activity Inhibitor
Patent: 6,004,813 →
Application: 08/945,726 →
Soluble Human Prolactin Receptors
Patent: 6,083,753 →
Application: 08/970,428 →
Methods for Detecting, Identifying, Isolating, and Selectively Labelling and Targeting TH1 Lymphocyte by Means of the Lag-3 Protein
Patent: 6,197,524 →
Application: 08/983,576 →
Soluble Polypeptide Fractions of the Lag-3 Protein; Production Method, Therapeutic Composition, Anti-Idiotype Antibodies
Patent: 6,143,273 →
Application: 09/058,555 →
Use of Human Chorionic Gonadotropin in the Treatment of Kaposi's Sarcoma
Patent: 6,251,402 →
Application: 09/101,640 →
Disulfide Crosslinked Glycoprotein Hormone Analogs, and Their Preparation and Use
Patent: 8,530,190 →
Application: 09/104,400 →
Il-6 Mutein
Patent: 6,280,975 →
Application: 09/155,941 →
Component B as Cicatrizant
Patent: 5,998,364 →
Application: 09/171,659 →
Compounds That Inhibit the Binding of Raf-1 or 14-3-3 Proteins to the Beta Chain of Il-2 Receptor, and Pharmaceutical Compositions Containing Same
Patent: 6,281,193 →
Application: 09/194,145 →
Publication: US 2001/0016194
IFNAR2/Ifn Complex
Patent: 6,372,207 →
Application: 09/215,212 →
Human Fcy Receptor Iii
Patent: 6,294,347 →
Application: 09/232,218 →
Hcg and Derivatives as Matrix Metalloproteases Inhibitors
Patent: 6,444,639 →
Application: 09/242,099 →
Publication: US 2001/0006940
Ice Inhibiting Peptides
Patent: 6,380,162 →
Application: 09/297,369 →
Methods for Preventing Graft Rejection in Transplantation and for Producing a Universal Gene Therapy Host Cell Using Lymphocyte Activation (Lag-3)
Patent: 6,500,422 →
Application: 09/319,147 →
Publication: US 2002/0081282
Intracellular Glucocorticoid-Induced Leucine Zippers Modulators of Apoptic Cell Death Pathways
Patent: 6,833,348 →
Application: 09/403,861 →
Pharmaceutical Compositions Thereof, and Methods of Using Same
Patent: 6,337,316 →
Application: 09/460,384 →
Human Growth Hormone to Stimulate Hematopoiesis and Immune Reconstitution After Hematopoietic Stem Cell Transplantation in Humans
Patent: 6,348,444 →
Application: 09/465,461 →
Treatment of Hiv-Associated Dysmorphia/Dysmetabolic Syndrome (Hadds) with or Without Lipodystrophy
Patent: 6,696,063 →
Application: 09/475,989 →
Use of Mhc Class Ii Ligands as Adjuvant for Vaccination and of Lag-3 in Cancer Treatment
Patent: 6,410,509 →
Application: 09/492,113 →
Allelic variant of human stat3
Patent: 6,369,198 →
Application: 09/526,542 →
Method for Producing a Heterologous Secreted Protein from Chinese Hamster Ovary Cells Grown on Microcarriers
Application: 60/152,311 →
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Dec 21, 1987
From: CHAPPEL, SCOTT C.; BERNSTINE, EDWARD G.
To: INTEGRATED GENETICS, INC., FRAMINGHAM
Reel/Frame 004806/0323 →
Assignment of Assignors Interest. Feb 7, 1989
From: ARPAIA, GUISEPPE; SERANI, SERENELLA; SIRNA, ANTONINO; VILLA, STEFANO
To: ISTITUTO DI RICERCA CESARE SERONO SPA.
Reel/Frame 005078/0188 →
Assignment of Assignors Interest. Jul 24, 1989
From: ORTEGA, ANTONIO D.; GIL, JOSE A.; GARCIA, TOMAS V.; MARTIN, JUAN F.
To: LABORATORIES SERONO S.A., C/GENOVA, 17 - PLANTA 6, 28004 MADRID - SPAIN
Reel/Frame 005104/0281 →
Assignment of Assignors Interest. Sep 1, 1989
From: INTEGRATED GENETICS, INC.
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V., JOHN B. GORSIRAWEG
Reel/Frame 005138/0773 →
Assignment of Assignors Interest. Mar 30, 1990
From: INTEGRATED GENETICS, INC.
To: GENZYME CORPORATION, 75 KNEELAND STREET, BOSTON, MA 02111 A DE CORP.
Reel/Frame 005264/0732 →
Assignment of Assignors Interest. Mar 6, 1991
From: LABORATORIOS SERONO S.A.
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 005623/0426 →
Assignment of Assignor's Interest Jun 10, 1993
From: CHAPPEL, SCOTT C.
To: APPLIED RESEARCH SYSTEMS
Reel/Frame 006581/0638 →
Assignment of Assignor's Interest Dec 3, 1993
From: JEM, KWAN-MIN; CEVEY, PIERRE FRANCOIS
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 006794/0312 →
Assignment of Assignor's Interest Jan 26, 1994
From: AKERLOF, EVA; POUSETTE, AKE
To: AKERLOF, EVA; POUSETTE, AKE; APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 006847/0093 →
Assignment of Assignor's Interest Sep 7, 1994
From: SAMARITANI, FABRIZIO; NATALE, PATRIZIA
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 007112/0125 →
Assignment of Assignor's Interest Sep 26, 1995
From: SISK, WILLIAM P.; CHENG, SHIRLEY VUI YEN; BUCKLER, DAVID ROGERS; PRENTICE, HOLLY LYNN
To: APPLIED RESEARCH SYSTEMS, ARS HOLDINGS N.V.
Reel/Frame 007637/0989 →
Assignment of Assignor's Interest Oct 23, 1995
From: LUO, SHUN
To: APPLIED RESEARCH SYSTEM ARS HOLDING N.V.
Reel/Frame 007672/0791 →
Assignment of Assignor's Interest Nov 13, 1995
From: COLOTTA, FRANCESCO; MUZIO, MARTA; MANTOVANI, ALBERTO
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 007724/0136 →
Assignment of Assignor's Interest Aug 11, 1996
From: SIRNA, ANTONINO
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 008073/0281 →
Assignment of Assignor's Interest Mar 21, 1997
From: SCHERING CORPORATION
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 008411/0080 →
Assignment of Assignor's Interest Mar 26, 1997
From: FAURE, FLORENCE; HERCEND, THIERRY; HUARD, BERTRAND; TRIEBEL, FREDERIC
To: INSTITUT GUSTAVE ROUSSY; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 008416/0695 →
Assignment of Assignor's Interest Sep 22, 1997
From: CAMPBELL, ROBERT; JAMESON, BRADFORD A.; CHAPPEL, SCOTT C.
To: APPLIED RESEARCH SYSTEMS ARS HOLDING NV
Reel/Frame 008717/0790 →
Change of Address Oct 27, 2000
From: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 011245/0159 →
Assignment of Assignor's Interest Sep 11, 2007
From: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
To: LABORATOIRES SERONO SA
Reel/Frame 019966/0026 →
Merger Mar 20, 2008
From: ISTITUTO DI RICERCA CESARE SERONO S.P.A.
To: INDUSTRIA FARMACEUTICA SERONO S.P.A.
Reel/Frame 020679/0142 →
Corrective Assignment to Correct the Incorrect Serial Numbers 07/244,575 and 08/074,465 Previously Recorded on Reel 019966 Frame 0026. Assignor(S) Hereby Confirms the Assignment of Entire Interest. Apr 23, 2009
From: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
To: LABORATOIRES SERONO SA
Reel/Frame 022587/0160 →
Change of Name Nov 25, 2009
From: LABORATOIRES SERONO SA
To: MERCK SERONO SA
Reel/Frame 023569/0120 →